Another HIV protease inhibitor, Nelfinavir, was previously shown to be able to decrease levels of the survivin protein in combination therapy with imatinib when used on primary meningioma cells and meningioma cell lines IOMM-Lee and CH157. The gene discussed is BIRC5; the disease is meningioma.